Learn more about investing in CASPR Biotech

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
CASPR Biotech
Accelerating CRISPR diagnostics
CONTACT COMPANY INVESTOR INQUIRIES
Healthcare IBSF08 2019 Seed Female Founder Future of Medicine San Francisco
* Data source: Crunchbase
Founded
2018
Employees*
11-50
Funding to Date*
$2.6M
* Data source: Crunchbase
Franco Goytia, CEO
Other CRISPR systems exist in nature—we mounted expeditions throughout South America and Antarctica searching hostile environments (such as deserts, high altitude regions, and environments with high salinity and high UV radiation) for organisms with novel CRISPR systems. Our company’s portfolio of enzymes includes unique functionalities which typically correlate with the enzymes’ original environments.
Many CRISPR systems operate at temperatures around 37°C. However, those temperatures are not compatible with isothermal amplification, which functions best at 62–64°C.

What do you do when all the Cas proteins get locked up in IP because of the CRISPR war? You go to the ends of the earth to find an undiscovered Cas protein. And that’s what the Caspr team did, traveling to high-altitude mountains and volcanoes to find extremophiles in Argentina where there might be a Cas protein whose upbringing might endow them with temperature resistance.

Caspr has been acquired by a Fortune 100 company.
Now Caspr is using their special Cas to develop cheap and rapid CRISPR-based test kits ƒor infectious diseases. One month after they graduated from IndieBio, COVID-19 hit and Caspr’s team knew exactly what they had to do. They flew out their scientists out of Argentina to come live in San Francisco, where 15 of them lived in a single house in Alamo Square, all trying to develop tests for the coronavirus.

After demonstrating how rapidly they were able to develop their tests, Caspr was approached by Amazon to help with their internal efforts to test their employees.

Team
Lucia Curti
Co-Founder
Carla Gimenez
Co-Founder
Franco Goytia
CEO & Co-Founder
Company News
The New York Times | May 05, 2020
With Crispr, a Possible Quick Test for the Coronavirus
A pioneer of the gene-editing technology has devised a diagnostic test for the infection that could be as simple as a pregnancy test.
Contxto | November 26, 2019
CASPR Biotech could become the Mercado Libre of molecular diagnostics
CASPR biotech is based on CRISPR. A newly discovered technology that caused a great furor due to its potential to literally change the genes in your body.
Contxto | January 15, 2020
10 biotechs rewriting Argentina's startup DNA
From miniscule molecules, to buzzing bees, these biotech startups from Argentina are reengineering the natural world as we know it—for the better.
SEE ALL NEWS

More Companies

Aluna Medical Diagnostics
BiomeSense
BioROSA Technologies Inc.
SEE ALL COMPANIES